Increase efficiencies and productivity by automating core reporting tasks for medical writing.
Automate core regulatory report documents across the CTD pyramid and dramatically accelerate submission timelines.
Accelerate regulatory documentation with automation that reduces drafting time, increases team capacity and ensures compliance.
Already trusted by global pharma leaders for automating clinical content, we have expanded our Copilot platform to support CMC documentation. The first release focuses on the QOS, delivering the same regulatory-grade accuracy and scalability that define our clinical solutions. This launch reinforces our leadership in intelligent automation for regulatory document generation.
Cut drafting time from weeks to minutes while ensuring accuracy and consistency across CSRs, patient narratives, and more.
AI-driven workflows streamline updates, reduce back-and-forth, and enable teams to collaborate seamlessly.
Automate regulatory checks, track changes, and maintain audit readiness—delivering submission-ready documents with confidence.
Intelligent Document Creation, Collaboration, and Compliance
Produce regulatory and medical documents in minutes, not weeks. Ensure consistency, accuracy, and compliance while reducing manual effort.
Break silos with structured workflows, real-time updates, and automated review processes—enabling regulatory, medical, and cross-functional teams to stay aligned.
Integrate regulatory standards directly into document creation, automating compliance checks and minimizing risk.
From clinical documentation to quality reviews, Yseop Copilot adapts to your team’s unique workflows—delivering high-quality reports at scale.
See how Yseop Copilot eliminates inefficiencies, enhances compliance, and accelerates approvals—so you can bring treatments to market faster.
Recognized for groundbreaking GenAI solutions transforming the pharma industry.
A recognition of our innovation and excellence in leveraging AI technology.
2024 finalist in Business Intelligence Group’s Artificial Intelligence Excellence Awards.
Winner in the Healthcare and Life Sciences category
At the forefront of innovations and developments in Generative AI and Life Sciences
Claret Capital Partners has invested €10M in Yseop to support global expansion and accelerate development of its Generative AI platform. Yseop Copilot helps leading pharma companies like Eli Lilly and Novartis create compliant regulatory documentation faster and with greater consistency.
Yseop’s first CMC-focused offering automates the Quality Overall Summary (Module 2.3), a central component of regulatory submissions that pulls structured insights from Module 3.2.
With 27,000+ reports generated per month, Yseop solidifies its leadership in regulatory automation ahead of its DIA 2025 showcase.
Let’s start automating your data to narratives today!